Vir Biotechnology Inc (VIR)

$ 4.38
   
  • Change Today:
    $0.02
  • 52 Week High: $12.48
  • 52 Week Low: $4.25
  • Currency: US Dollars
  • Volume: 829,630
  • RiskGrade: 878
  • Beta: 0.03

Latest ShareCast News

GSK and Vir Biotechnology to supply EU with Covid-19 treatment

By Alexander Bueso

Date: Wednesday 28 Jul 2021

(Sharecast News) - GlaxoSmithKline has inked a joint procurement deal with Brussels for its Covid-19 treatment Sotrovimab together with its partner Vir Biotechnology.

Glaxo, Vir stop Covid trial early after drug shows 85% efficacy

By Frank Prenesti

Date: Thursday 11 Mar 2021

(Sharecast News) - Drug companies GlaxoSmithKline and Vir Biotechnology have been advised to finish a final trial of their Covid-19 drug early due to its "profound efficacy".

GSK, Vir to collaborate on new therapeutics for influenza

By Michele Maatouk

Date: Wednesday 17 Feb 2021

(Sharecast News) - GlaxoSmithKline and Vir Biotechnology will expand their existing collaboration to include the research and development of new therapies for influenza and other respiratory viruses.

GSK joins up with Vir Biotech on coronavirus tre... 06-Apr-2020 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VIR Market Data

Currency US Dollars
Share Price $ 4.38
Change Today $ 0.02
% Change 0.46 %
52 Week High $12.48
52 Week Low $4.25
Volume 829,630
Beta 0.03
RiskGrade 878

Trades for 21-Aug-2025

Time Volume / Share Price
16:00 88,201 @ $4.38
15:59 100 @ $4.38
15:59 100 @ $4.38
15:59 100 @ $4.38
15:59 200 @ $4.37

Top of Page